2m 2m 2m 2m 2m 2m 2m
NUVALENT-A (NUVL)
NASDAQ
$123.45+$0.02 (+0.02%)
Price as of Jun 23, 2026 4:10 PM EDT- $9.1BMarket Cap
- 62.44%1-Year Change
- BiotechnologyIndustry
NUVALENT-A (NUVL)
$123.45+$0.02 (+0.02%)
NUVL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $123.42 | ||
Change | -$0.01 (-0.008%) | ||
Open | $123.50 | ||
High | $123.56 | ||
Low | $123.38 | ||
Previous Close | $123.43 | ||
Volume | 2,094,308 | ||
30-Day Average Volume | 5,291,294 | ||
1-Week Change | 0.06% | ||
1-Month Change | 20.86% | ||
1-Year Change | 62.44% | ||
3-Year Change | 193.37% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 73.7M | ||
Total Assets | $1.3B | ||
Market Cap | $9.1B | ||
Enterprise Value | $8.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$109.3M | ||
Free Cash Flow | -$92.4M | ||
EBIT | -$109.1M | ||
EBITDA | -$109.1M | ||
Net Working Capital | $1.2B | ||
EPS | -$1.39 | ||
Enterprise Value/EBITDA | -82 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 8 | ||
P/E | -89 | ||
PEG | -7 | ||
Price/Free Cash Flow | -98 | ||
Price/Operating Cash Flow | -98 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 1200000 | ||
Last Split Date | 03/10/2017 | ||
Earnings & Revenue